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PurposeTo delineate some of the characteristics of septic vascular hypotension, to
assess the most commonly cited and reported underlying mechanisms of vascular
hyporesponsiveness to vasoconstrictors in sepsis, and to briefly outline current
therapeutic strategies and possible future approaches. Methods Source data were
obtained from a PubMed search of the medical literature with the following MeSH
terms: Muscle, smooth, vascular/physiopathology; hypotension/etiology;
shock/physiopathology; vasodilation/physiology; shock/therapy; vasoconstrictor
agents. Results Nitric oxide (NO) and peroxynitrite are crucial components
implicated in vasoplegia and vascular hyporeactivity. Vascular ATP-sensitive and
calcium-activated potassium channels are activated during shock and participate in
hypotension. In addition, shock state is characterized by inappropriately low plasma
glucocorticoid and vasopressin concentrations, a dysfunction and desensitization of
alpha-receptors, and an inactivation of catecholamines by oxidation. Numerous other
mechanisms have been individualized in animal models, the great majority of which
involve NO: MEK1/2–ERK1/2 pathway, H2S, hyperglycemia, and cytoskeleton
dysregulation associated with decreased actin expression. Conclusions Many
therapeutic approaches have proven their efficiency in animal models, especially
therapies directed against one particular compound, but have otherwise failed when
used in human shock. Nevertheless, high doses of catecholamines, vasopressin and
terlipressin, hydrocortisone, activated protein C, and non-specific shock treatment
have demonstrated a partial efficiency in reversing sepsis-induced hypotension.
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